In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Regityn Drug Master File in Korea (Regityn KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Regityn. The MFDS reviews the Regityn KDMF as part of the drug registration process and uses the information provided in the Regityn KDMF to evaluate the safety and efficacy of the drug.
After submitting a Regityn KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Regityn API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Regityn suppliers with KDMF on PharmaCompass.